Initial Hemodialysis with a Temporary Catheter Is Associated with Complications of a Later Permanent Vascular AccessZhu M. · Zhang W. · Zhou W. · Zhou Y. · Fang Y. · Wang Y. · Zhang H. · Yan Y. · Ni Z. · Qian J.
Renal Division, Renji Hospital, School of Medicine, Shanghai Jiaotong University, Shanghai, China
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
The aim was to identify the risk factors of long-term vascular access complications. The study cohort consisted of 239 incident hemodialysis (HD) patients from 1998 to 2010 in a single center. Among these patients, 59.8% had initially been dialyzing with a temporary catheter. Within 3 months after starting dialysis, all catheters had been converted into permanent accesses. 45 patients incurred long-term access complications after the first 2 years of dialysis, and 34 (75.6%) had used a temporary catheter starting HD. Complication occurrence was associated with age, initiation dialysis with a catheter and heart failure by logistic regression (odds ratios were 1.04, 2.77 and 2.23, respectively; p < 0.05). The 2-year primary patency rates of arteriovenous fistulae were significantly higher than those of arteriovenous grafts (79.5 vs. 50%, p = 0.002). We concluded that age, using a catheter and heart failure in HD initiation had a strong impact on long-term access complications.
© 2014 S. Karger AG, Basel
- Scribner BH, Buri R, Caner JE, Hegstrom R, Burnell JM: A preliminary report. Trans Am Soc Artif Intern Organs 1960;6:114-122.
- Brescia MJ, Cimino JE, Appel K, Hurwich BJ: Chronic hemodialysis using venipuncture and a surgically created arteriovenous fistula. N Engl J Med 1966;275:1089-1092.
- Besarab A: Resolved: fistulas are preferred to grafts as initial vascular access for dialysis. Proc J Am Soc Nephrol 2008;19:1629-1631.
NKF-K/DOQI clinical practice guidelines for vascular access: update 2006. Am J Kidney Dis 2006;48(suppl 1):S177-S322.
- Tordoir J, Canaud B, Haage P, Konner K, Basci A, Fouque D, Kooman J, Martin-Malo A, Pedrini L, Pizzarelli F, Tattersall J, Vennegoor M, Wanner C, ter Wee P, Vanholder R: EBPG on vascular access. Nephrol Dial Transplant 2007;22(suppl 2):ii88-ii117.
- Jindal K, Chan CT, Deziel C, Hirsch D, Soroka SD, Tonelli M, Culleton BF: Canadian Society of Nephrology Committee for Clinical Practice Guidelines: Hemodialysis clinical practice guidelines for the Canadian Society of Nephrology. J Am Soc Nephrol 2006;17(suppl 1):S1-S27.
- Ethier J, Mendelssohn DC, Elder SJ, Hasegawa T, Akizawa T, Akiba T, Canaud BJ, Pisoni RL: Vascular access use and outcomes: an international perspective from the dialysis outcomes and practice patterns study. Nephrol Dial Transplant 2008;23:3219-3226.
Shanghai Renal Registry Network: Shanghai Dialysis Registry Annual Report, 2011. http://sh.cnrds.org.
- Woo K, Doros G, Ng T, Farber A: Comparison of the efficacy of upper arm transposed arteriovenous fistulae and upper arm prosthetic grafts. J Vasc Surg 2009;50:1405-1411.
- Hazinedaroğlu SM, Tüzüner A, Ayli D, Demirer S, Duman N, Yerdel MA: Femoral vein transposition versus femoral loop grafts for hemodialysis: a prospective evaluation. Transplant Proc 2004;36:65-67.
- Pflederer TA, Kwok S, Ketel BL, Pilgram T: A comparison of transposed brachiobasilic fistulae with nontransposed fistulae and grafts in the fistula-first era. Semin Dial 2008;21:357-363.
- Basel H, Ekim H, Odabasi D, Kiymaz A, Aydin C, Dostbil A: Basilic vein transposition fistulas versus prosthetic bridge grafts in patients with end-stage renal failure. Ann Vasc Surg 2011;25:634-639.
- Elseviers MM, Van Waeleghem JP; European Dialysis and Transplant Nurses Association/European Renal Care Association: Identifying vascular access complications among ESRD patients in Europe. A prospective, multicenter study. Nephrol News Issues 2003;17:61-64, 66-68, 99.
- Mann B, Tonelli M, Yilmaz S, Lee H, Laupland K, Klarenbach S, Radkevich V, Murphy B: Establishment and maintenance of vascular access in incident hemodialysis patients: a prospective cost analysis. J Am Soc Nephrol 2005;16:201-209.
- Allon M, Robbin ML: Increasing arteriovenous fistulas in hemodialysis patients: problems and solutions. Kidney Int 2002;62:1109-1124.
- Huijbregts HJ, Bots ML, Wittens CH, Schrama YC, Blankestijn PJ: Access blood flow and the risk of complications in mature forearm and upper arm arteriovenous fistulas. Blood Purif 2009;27:212-219.
- Monroy-Cuadros M, Yilmaz S, Salazar-Bañuelos A, Doig C: Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clin J Am Soc Nephrol 2010;5:1787-1792.
- Arce CM, Mitani AA, Goldstein BA, Winkelmayer WC: Hispanic ethnicity and vascular access use in patients initiating hemodialysis in the United States. Clin J Am Soc Nephrol 2012;7:289-296.
- Wasse H, Speckman RA, Frankenfield DL, Rocco MV, McClellan WM: Predictors of central venous catheter use at the initiation of hemodialysis. Semin Dial 2008;21:346-351.
- Antón-Pérez G, Pérez-Borges P, Alonso-Almán F, Vega-Díaz N: Vascular accesses in haemodialysis: a challenge to be met. Nefrologia 2012;32:103-107.
- Pisoni RL, Arrington CJ, Albert JM, Ethier J, Kimata N, Krishnan M, Rayner HC, Saito A, Sands JJ, Saran R, Gillespie B, Wolfe RA, Port FK: Facility hemodialysis vascular access use and mortality in countries participating in DOPPS: an instrumental variable analysis. Am J Kidney Dis 2009;53:475-491.
- Pérez-García R, Martín-Malo A, Fort J, Cuevas X, Lladós F, Lozano J, García F; ANSWER Study: Baseline characteristics of an incident haemodialysis population in Spain: results from ANSWER - a multicentre, prospective, observational cohort study. Nephrol Dial Transplant 2009;24:578-588.
- Gehan EA, George SL: Estimation of human body surface area from height and weight. Cancer Chemother Rep 1970;54:225-235.
- Keys A, Fidanza F, Karvonen MJ, Kimura N, Taylor HL: Indices of relative weight and obesity. J Chron Dis 1972;25:329-343.
- Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976;16:31.
- Lok CE, Allon M, Moist L, Oliver MJ, Shah H, Zimmerman D: Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I). J Am Soc Nephrol 2006;17:3204-3212.
- Sidawy AN, Gray R, Besarab A, Henry M, Ascher E, Silva M Jr, Miller A, Scher L, Trerotola S, Gregory RT, Rutherford RB, Kent KC: Recommended standards for reports dealing with arteriovenous hemodialysis accesses. J Vasc Surg 2002;35:603-610.
- Ravani P, Barrett B, Mandolfo S, Brunori G, Camcarini G, Imbasciati E, Malberti F: Factors associated with unsuccessful utilization and early failure of the arteriovenous fistula for hemodialysis. J Nephrol 2005;18:188-196.
- Weyde W, Letachowicz W, Kusztal M, Porazko T, Krajewska M, Klinger M: Outcome of autogenous fistula construction in hemodialyzed patients over 75 years of age. Blood Purif 2006;24:190-195.
- Astor BC, Eustace JA, Powe NR, Klag MJ, Sadler JH, Fink NE, Coresh J: Timing of nephrologist referral and arteriovenous access use: the CHOICE study. Am J Kidney Dis 2001;38:494-501.
- Lee T, Barker J, Allon M: Associations with predialysis vascular access management. Am J Kidney Dis 2004;43:1008-1013.
- Vassalotti JA, Jennings WC, Beathard GA, Neumann M, Caponi S, Fox CH, Spergel LM; Fistula First Breakthrough Initiative Community Education Committee: Fistula first breakthrough initiative: targeting catheter last in fistula first. Semin Dial 2012;25:303-310.
- Moist LM, Trpeski L, Na Y, Lok CE: Increased hemodialysis catheter use in Canada and associated mortality risk: data from the Canadian Organ Replacement Registry 2001-2004. Clin J Am Soc Nephrol 2008;3:1726-1732.
- Bradbury BD, Chen F, Furniss A, Pisoni RL, Keen M, Mapes D, Krishnan M: Conversion of vascular access type among incident hemodialysis patients: description and association with mortality. Am J Kidney Dis 2009;53:804-814.
- Foley RN, Chen SC, Collins AJ: Hemodialysis access at initiation in the United States, 2005 to 2007: still ‘catheter first'. Hemodial Int 2009;13:533-542.
- Ng LJ, Chen F, Pisoni RL, Krishnan M, Mapes D, Keen M, Bradbury BD: Hospitalization risks related to vascular access type among incident US hemodialysis patients. Nephrol Dial Transplant 2011;26:3659-3666.
- Perl J, Wald R, McFarlane P, Bargman JM, Vonesh E, Na Y, Jassal SV, Moist L: Hemodialysis vascular access modifies the association between dialysis modality and survival. J Am Soc Nephrol 2011;22:1113-1121.
- Oliver MJ, Rothwell DM, Fung K, Hux JE, Lok CE: Late creation of vascular access for hemodialysis and increased risk of sepsis. J Am Soc Nephrol 2004;15:1936-1942.
- Sands JJ: Increasing AV fistulae and decreasing dialysis catheters: two aspects of improving patient outcomes. Blood Purif 2007;25:99-102.
- Lopot F, Nejedlý B, Válek M: Vascular access monitoring: methods and procedures - something to standardize? Blood Purif 2005;23:36-44.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.